FAAH is needed for AEA reuptake and metabolism, and FAAH inhibitors are suggested to increase synaptic AEA leading to beneficial therapeutic effects in models of chronic pain, anxiety, or depression [52,53,54,55,56]. Here, FAAH is linked to major depressive disorder.